Respiratory changes during treatment of postoperative pain with high dose transdermal fentanyl
- PMID: 7484044
- DOI: 10.1111/j.1399-6576.1995.tb04180.x
Respiratory changes during treatment of postoperative pain with high dose transdermal fentanyl
Abstract
This study made a longterm (72 hours) evaluation of the efficacy and possible side-effects of transdermal delivery of fentanyl (TTS-system) for post-operative pain relief. The study was double-blind, placebo-controlled with either a TTS-system delivering fentanyl 100 micrograms.h-1 and rescue analgesic on demand or a placebo system and analgesic on demand. Analgesic consumption, pain, general satisfaction, respiratory rate, and levels of SpO2 and tcCO2 (pulse oximetry and transcutaneous CO2 measuring) were evaluated. Recruitment was stopped after enrolment of 24 patients, on safety grounds. The Fentanyl group was more satisfied with postoperative pain relief (P = 0.008); they had a lower analgesic demand (P < 0.05) but also a lower respiratory rate (P < 0.05) and a higher level of tcCO2 23 hours after application (P < 0.05). There were three cases (25%) of increased PaCO2 (> 6.5 kPa) in the Placebo group but without low PaO2 levels, sedation or bradypnoea. Conversely, there were three cases (33%) in the Fentanyl group with bradypnoea (< 10 breaths/minute), two without influence on PaO2 or PaCO2, but one (no. 24) with bradypnoea, heavy sedation, a marked decrease in PaO2 (5.8 kPa) and increased PaCO2 (7.5 kPa). These findings terminated the study. The 100 micrograms transdermal fentanyl system is agreeable to the patients, but apparently too potent for routine postoperative pain relief due to a risk of respiratory depression. Respiratory frequency can not be relied upon as sole indicator of insufficient respiration.
Similar articles
-
Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl.Clin Pharmacokinet. 2000 Jan;38(1):59-89. doi: 10.2165/00003088-200038010-00004. Clin Pharmacokinet. 2000. PMID: 10668859 Review.
-
Postoperative analgesia with parenteral opioids: does continuous delivery utilizing a transdermal opioid preparation affect analgesic efficacy or patient safety?J Clin Anesth. 1997 May;9(3):173-8. doi: 10.1016/s0952-8180(97)00043-3. J Clin Anesth. 1997. PMID: 9172021 Clinical Trial.
-
A double-blind, placebo-controlled trial of transdermal fentanyl after abdominal hysterectomy. Analgesic, respiratory, and pharmacokinetic effects.Anesthesiology. 1994 Nov;81(5):1169-80; discussion 26A. doi: 10.1097/00000542-199411000-00010. Anesthesiology. 1994. PMID: 7978475 Clinical Trial.
-
Transdermal fentanyl system plus im ketorolac for the treatment of postoperative pain.Can J Anaesth. 1997 Apr;44(4):377-84. doi: 10.1007/BF03014457. Can J Anaesth. 1997. PMID: 9104519 Clinical Trial.
-
Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control.Drugs. 1997 Jan;53(1):109-38. doi: 10.2165/00003495-199753010-00011. Drugs. 1997. PMID: 9010652 Review.
Cited by
-
Transdermal fentanyl as an adjuvant to paravertebral block for pain control after breast cancer surgery: A randomized, double-blind controlled trial.Saudi J Anaesth. 2017 Oct-Dec;11(4):384-389. doi: 10.4103/sja.SJA_84_17. Saudi J Anaesth. 2017. PMID: 29033716 Free PMC article.
-
Transdermal fentanyl patch for postoperative analgesia in total knee arthroplasty: a randomized double-blind controlled trial.J Pain Res. 2014 Aug 1;7:449-54. doi: 10.2147/JPR.S66741. eCollection 2014. J Pain Res. 2014. PMID: 25120375 Free PMC article.
-
Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain.Drug Saf. 2003;26(13):951-73. doi: 10.2165/00002018-200326130-00004. Drug Saf. 2003. PMID: 14583070 Review.
-
Oral morphine and respiratory function amongst hospice inpatients with advanced cancer.Support Care Cancer. 2003 Dec;11(12):780-4. doi: 10.1007/s00520-003-0530-0. Epub 2003 Oct 24. Support Care Cancer. 2003. PMID: 14577019
-
Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl.Clin Pharmacokinet. 2000 Jan;38(1):59-89. doi: 10.2165/00003088-200038010-00004. Clin Pharmacokinet. 2000. PMID: 10668859 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources